AstraZeneca surges after HHS provides $500 million for Covid-19 antibody treatment development

AstraZeneca are working on a new COVID 19 antibody treatmentПодробнее

AstraZeneca's antibody therapy prevents COVID-19Подробнее

AstraZeneca starts trials of virus treatmentПодробнее

AstraZeneca's antibody cocktail helps prevent Covid for at least 6 monthsПодробнее

AstraZeneca and U.S. strike deal to develop Covid-19 antibody drug supplyПодробнее

Astrazeneca asks FDA to authorize COVID antibody treatmentПодробнее

ER doctor discusses AstraZeneca's COVID-19 vaccine and a new antibody treatmentПодробнее

Coronavirus infections in Germany top 1 million, AstraZeneca plans new vaccine trials | DW NewsПодробнее

The latest on AstraZeneca’s COVID-19 vaccine developmentПодробнее

AstraZeneca says its COVID-19 vaccine is safe and highly effective after U.S. clinical trialПодробнее

AstraZeneca president talks COVID-19 antibody treatment, vaccines, and OmicronПодробнее

AstraZeneca’s COVID-19 vaccine and clotting risksПодробнее

AstraZeneca COVID-19 antibody under reviewПодробнее

AstraZeneca Covid Antibody Cocktail Only 33% EffectiveПодробнее

AstraZeneca seeks U.S. approval for new COVID treatmentПодробнее

AstraZeneca resumes trial of COVID antibodyПодробнее

AstraZeneca's COVID-19 antibody drug Evusheld to arrive in Singapore by end-2021Подробнее

The First Covid Vaccines May Not Prevent Covid InfectionПодробнее

AstraZeneca seeks FDA authorization for antibody treatmentПодробнее